2.63
price down icon4.36%   -0.12
after-market Handel nachbörslich: 2.63
loading

Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
26.89%
2.3398
3.2003 3.2257 2.8837 3.2036
Operating Income/Loss
26.89%
-2.3398
-3.2003 -3.2257 -2.8837 -3.2036
Income/Loss From Continuing Operations Before Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Income/Loss From Continuing Operations After Tax
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 -3.1343
Net Income/Loss
26.89%
-2.3036
-3.1509 -3.1732 -2.8291 3.1343
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.1547
- - - -
Diluted Average Shares
5.1547
- - - -
Basic Earnings Per Share
-0.45
- - - -
Diluted Earnings Per Share
-0.45
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):